Literature DB >> 9742974

Gains and losses from dexamethasone for neonatal chronic lung disease.

A Greenough1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742974     DOI: 10.1016/S0140-6736(05)60002-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed.

Authors:  W Tarnow-Mordi; A Mitra
Journal:  BMJ       Date:  1999-11-27

Review 2.  Weaning from assisted ventilation: art or science?

Authors:  S K Sinha; S M Donn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

3.  Randomised trial of fluid restriction in ventilated very low birthweight infants.

Authors:  V Kavvadia; A Greenough; G Dimitriou; R Hooper
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

4.  A scoring system to predict chronic oxygen dependency.

Authors:  Caroline May; Valia Kavvadia; Gabriel Dimitriou; Anne Greenough
Journal:  Eur J Pediatr       Date:  2006-08-08       Impact factor: 3.183

5.  Glucocorticoids inhibit production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.

Authors:  Yun Chen; Min Zhang; Yijie Zheng
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 6.  The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants.

Authors:  M A Crawford; I Golfetto; K Ghebremeskel; Y Min; T Moodley; L Poston; A Phylactos; S Cunnane; W Schmidt
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.